Ruobing Ma

Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report

Haibo Mou, Lanfang Yu, Qin Liao et al. · BMC Cancer · 2018 · 65 citations · Full text

Medicine, Immunology, Oncology +17

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients

Xueqin Chen, Dadong Chen, Shaoyu Yang et al. · Cancer Cell International · 2015 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16

The landscape of NTRK fusions in Chinese patients with solid tumor

Qi Ling, Bowen Li, Xinglong Wu et al. · Annals of Oncology · 2018 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +16

Carcinoma of Unknown Primary with<i>EML4-ALK</i>Fusion Response to<i>ALK</i>Inhibitors

Peng Zhao, Ling Peng, Wei Wu et al. · The Oncologist · 2019 · 14 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Abstract 4613: The difference of molecular signatures in left- and right-sided colorectal cancer Chinese patients

Sen Zhang, Yun Guo, Weibin Shu et al. · Cancer Research · 2018 · 11 citations

Medicine, Molecular Biology, Oncology +17